2026 Q2 Portfolio Activity
In 2026 Q2, Ally Bridge Group (NY) LLC maintained a portfolio of 39 distinct positions. The most significant new addition was DEFINIUM THERAPEUTICS INC, now representing 16.64% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing the position by 270.8%. Conversely, Ally Bridge Group (NY) LLC completely exited their position in PRAXIS PRECISION MEDICINES I.
Position History
hover any row below to update
Loading…
Total Positions
39
Quarter
2026 Q2
Top Holding
DFTX (16.6%)
Top 10 Concentration
70.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-39 of 39
Ally Bridge Group (NY) LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DFTX
CALL
DEFINIUM THERAP...
|
CALL Option | 16.64% | — |
#1
Prev: #—
|
9.5 |
—
|
400,000 | — |
NEW
|
400,000 | $18,816,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
CALL
ABIVAX SA
|
CALL Option | 14.73% | — |
#2
Prev: #—
|
9.0 |
—
|
125,000 | — |
NEW
|
125,000 | $16,657,500 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NERV
MINERVA NEUROSC...
|
Healthcare | 10.68% | 8.06% |
#3
1
Prev: #2
|
7.5 |
—
|
520,302 | 31.4% |
P
S
|
2,175,802 | $12,075,701 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PMN
PROMIS NEUROSCI...
|
Healthcare | 7.22% | 4.25% |
#4
6
Prev: #10
|
5.9 |
—
|
206,100 | 49.8% |
P
S
|
620,319 | $8,163,398 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
FIRST TRACKS BI...
|
|
Unknown | 5.06% | — |
#5
Prev: #—
|
6.0 |
—
|
284,287 | — |
NEW
|
284,287 | $5,719,854 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 3.57% | — |
#6
Prev: #—
|
4.9 |
—
|
16,493 | — |
NEW
|
16,493 | $4,036,992 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 3.40% | — |
#7
Prev: #—
|
4.9 |
—
|
140,000 | — |
NEW
|
140,000 | $3,847,200 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 3.31% | 2.28% |
#8
14
Prev: #22
|
2.3 |
—
|
no change | no change |
P
S
|
817,939 | $3,746,161 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 2.99% | 4.10% |
#9
2
Prev: #11
|
1.2 |
—
|
-77,700 | -48.3% |
P
S
|
83,300 | $3,384,479 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 2.87% | — |
#10
Prev: #—
|
4.6 |
—
|
249,172 | — |
NEW
|
249,172 | $3,249,203 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 2.81% | — |
#11
Prev: #—
|
4.6 |
—
|
290,000 | — |
NEW
|
290,000 | $3,181,300 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 2.57% | 3.42% |
#12
2
Prev: #14
|
1.5 |
—
|
-125,000 | -13.9% |
P
S
|
775,000 | $2,906,250 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 2.45% | — |
#13
Prev: #—
|
4.5 |
—
|
150,000 | — |
NEW
|
150,000 | $2,772,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 2.27% | — |
#14
Prev: #—
|
4.4 |
—
|
1,229,000 | — |
NEW
|
1,229,000 | $2,568,610 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 2.26% | 4.46% |
#15
7
Prev: #8
|
0.9 |
—
|
-511,015 | -66.6% |
P
S
|
255,959 | $2,557,030 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 2.25% | 1.45% |
#16
9
Prev: #25
|
1.9 |
—
|
no change | no change |
P
S
|
526,315 | $2,547,365 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 2.25% | 2.94% |
#17
2
Prev: #19
|
0.9 |
—
|
-132,941 | -65.8% |
P
S
|
69,183 | $2,545,934 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CATX
PERSPECTIVE THE...
|
Healthcare | 2.24% | 3.12% |
#18
2
Prev: #16
|
1.4 |
—
|
-182,599 | -19.7% |
P
S
|
743,958 | $2,536,897 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 2.22% | — |
#19
Prev: #—
|
4.4 |
—
|
67,500 | — |
NEW
|
67,500 | $2,515,725 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 2.12% | 3.34% |
#20
5
Prev: #15
|
1.3 |
—
|
-110,500 | -14.8% |
P
S
|
634,800 | $2,399,544 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 1.90% | 2.97% |
#21
3
Prev: #18
|
0.8 |
—
|
-90,500 | -54.2% |
P
S
|
76,459 | $2,151,556 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 1.49% | 5.05% |
#22
17
Prev: #5
|
0.6 |
—
|
-2,193,898 | -77.8% |
P
S
|
624,561 | $1,680,069 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 1.47% | 3.86% |
#23
10
Prev: #13
|
0.6 |
—
|
-408,200 | -61.8% |
P
S
|
252,175 | $1,666,877 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IBIO
IBIO INC
|
Healthcare | 0.60% | — |
#24
Prev: #—
|
3.7 |
—
|
390,147 | — |
NEW
|
390,147 | $682,757 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TRAW
TRAWS PHARMA IN...
|
Healthcare | 0.59% | — |
#25
Prev: #—
|
3.7 |
—
|
786,236 | — |
NEW
|
786,236 | $663,033 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KPTI
CALL
KARYOPHARM THER...
|
CALL Option | 0.00% | 1.12% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-250,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 0.00% | 1.18% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-210,525 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REPL
CALL
REPLIMUNE GROUP...
|
CALL Option | 0.00% | 1.53% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-246,900 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 0.00% | 1.80% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-1,325,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
CALL
MAZE THERAPEUTI...
|
CALL Option | 0.00% | 2.41% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-100,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 0.00% | 2.80% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-113,899 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.00% | 3.03% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-33,712 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
CALL
UNIQURE NV
|
CALL Option | 0.00% | 3.96% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-300,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPX
CALL
COMPASS THERAPE...
|
CALL Option | 0.00% | 4.27% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-1,000,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.00% | 4.58% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-80,859 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.00% | 4.67% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-1,045,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLNO
PUT
SOLENO THERAPEU...
|
PUT Option | 0.00% | 5.41% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-200,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 5.41% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-200,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 0.00% | 8.54% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-32,810 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-39 of 39 holdings